Alberta Health Services
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 2009-04-01
- Employees
- 10K
- Market Cap
- -
Onco-Innovations Partners with University of Alberta to Advance PNKP Inhibitor Research for Glioblastoma Treatment
Onco-Innovations has entered into a research agreement with the University of Alberta and Cross Cancer Institute to expand preclinical studies of its PNKP inhibitor technology for hard-to-treat cancers, beginning with glioblastoma multiforme.
Breakthrough Gene Therapy Eliminates Need for Enzyme Replacement in Fabry Disease Patients
Canadian researchers have successfully developed a one-time gene therapy treatment for Fabry disease that restored enzyme production to near-normal levels in all five trial participants within one week.